Cresset Asset Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Sell |
17,675
-1,322
| -7% | -$51.3K | ﹤0.01% | 921 |
|
|
2025
Q1 | $743K | Sell |
18,997
-1,695
| -8% | -$66.3K | ﹤0.01% | 882 |
|
|
2024
Q4 | $707K | Sell |
20,692
-41,175
| -67% | -$1.41M | ﹤0.01% | 919 |
|
|
2024
Q3 | $2.55M | Buy |
61,867
+7,527
| +14% | +$310K | 0.01% | 669 |
|
|
2024
Q2 | $2.11M | Buy |
54,340
+25,040
| +85% | +$973K | 0.01% | 680 |
|
|
2024
Q1 | $1.27M | Sell |
29,300
-1,001
| -3% | -$43.3K | 0.01% | 860 |
|
|
2023
Q4 | $1.13M | Buy |
30,301
+5,352
| +21% | +$200K | 0.01% | 826 |
|
|
2023
Q3 | $912K | Buy |
24,949
+375
| +2% | +$13.7K | ﹤0.01% | 867 |
|
|
2023
Q2 | $884K | Buy |
+24,574
| New | +$884K | ﹤0.01% | 868 |
|
|
2022
Q3 | – | Sell |
-6,098
| Closed | -$334K | – | 917 |
|
|
2022
Q2 | $334K | Sell |
6,098
-908
| -13% | -$49.7K | ﹤0.01% | 679 |
|
|
2022
Q1 | $386K | Sell |
7,006
-390
| -5% | -$21.5K | ﹤0.01% | 683 |
|
|
2021
Q4 | $412K | Buy |
7,396
+101
| +1% | +$5.63K | ﹤0.01% | 759 |
|
|
2021
Q3 | $353K | Buy |
7,295
+2,557
| +54% | +$124K | ﹤0.01% | 775 |
|
|
2021
Q2 | $239K | Sell |
4,738
-2,701
| -36% | -$136K | ﹤0.01% | 877 |
|
|
2021
Q1 | $332K | Buy |
7,439
+300
| +4% | +$13.4K | 0.01% | 631 |
|
|
2020
Q4 | $333K | Sell |
7,139
-2,354
| -25% | -$110K | 0.01% | 526 |
|
|
2020
Q3 | $453K | Sell |
9,493
-2,109
| -18% | -$101K | 0.01% | 392 |
|
|
2020
Q2 | $601K | Buy |
11,602
+6,443
| +125% | +$334K | 0.01% | 305 |
|
|
2020
Q1 | $252K | Sell |
5,159
-5,672
| -52% | -$277K | 0.01% | 446 |
|
|
2019
Q4 | $643K | Buy |
10,831
+140
| +1% | +$8.31K | 0.02% | 264 |
|
|
2019
Q3 | $576K | Buy |
+10,691
| New | +$576K | 0.02% | 246 |
|
|
2019
Q2 | – | Sell |
-6,056
| Closed | -$321K | – | 950 |
|
|
2019
Q1 | $321K | Buy |
6,056
+2,766
| +84% | +$147K | 0.01% | 252 |
|
|
2018
Q4 | $159K | Buy |
+3,290
| New | +$159K | 0.01% | 251 |
|